Glenmark Pharma Quarterly Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Glenmark Pharma Quarterly Results    (GLPH)

Here are the latest quarterly results of Glenmark Pharma. For more details, see the Glenmark Pharma financial fact sheet and Glenmark Pharma share price and chart. For a sector overview, read our pharmaceuticals sector report.

Excel Export | Annual Financial Info | Result Scoreboard

Glenmark Pharma Quarterly Results

No. of Mths
Qtr. Ending
3
Sep-17
*
3
Dec-17
*
3
Mar-18
*
3
Jun-18
*
3
Sep-18
*
3
Dec-18
*
3
Mar-19
*
3
Jun-19
*
8-Qtr Chart
Click to enlarge
Net Sales Rs m22,56622,03722,79821,65625,81325,55025,63523,229 
Other income Rs m297-2326961,3821,399-1,09039117 
Turnover Rs m22,86321,80523,49423,03827,21224,46026,02523,245 
Expenses Rs m18,68218,81019,53018,18721,41221,20421,99319,810 
Gross profit Rs m3,8843,2273,2683,4696,0734,3473,6413,419 
Depreciation Rs m752754735794825831810907 
Interest Rs m698705744790851885819930 
Profit before tax Rs m2,7311,5372,4853,2675,7961,5402,4031,598 
Tax Rs m5894899689371,656377786506 
Profit after tax Rs m2,1411,0471,5162,3304,1401,1631,6171,093 
Gross profit margin %17.214.614.316.023.517.014.214.7 
Effective tax rate %21.631.839.028.728.624.532.731.6 
Net profit margin %9.54.86.710.816.04.66.34.7 
Diluted EPS Rs 7.6 3.7 5.4 8.3 14.7 4.1 5.7 3.9  
Diluted EPS (TTM) Rs 42.1 28.9 28.5 24.9 32.0 32.4 32.8 28.4  
 Subscriber Feature View                
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Read: Glenmark Pharma 1QFY20 Result Performance Review

More Pharmaceuticals Company Quarterly Results:   DISHMAN PHARMA  BIOCON   WOCKHARDT  FRESENIUS KABI ONCO.  AUROBINDO PHARMA  

Compare GLENMARK PHARMA With:   DISHMAN PHARMA  BIOCON   WOCKHARDT  FRESENIUS KABI ONCO.  AUROBINDO PHARMA  

Compare GLENMARK PHARMA With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices Trade Marginally Higher; FMCG Stocks Advance(12:30 pm)

Share markets in India are presently trading on a positive note. The BSE Sensex is trading up by 76 points while the NSE Nifty is trading up by 12 points.

Views on news

GLENMARK PHARMA 2018-19 Annual Report Analysis (Annual Result Update)

Sep 5, 2019 | Updated on Sep 5, 2019

Here's an analysis of the annual report of GLENMARK PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of GLENMARK PHARMA. Also includes updates on the valuation of GLENMARK PHARMA.

GLENMARK PHARMA Announces Quarterly Results (1QFY20); Net Profit Down 53.1% (Quarterly Result Update)

Aug 28, 2019 | Updated on Aug 28, 2019

For the quarter ended June 2019, GLENMARK PHARMA has posted a net profit of Rs 1 bn (down 53.1% YoY). Sales on the other hand came in at Rs 23 bn (up 7.3% YoY). Read on for a complete analysis of GLENMARK PHARMA's quarterly results.

GLENMARK PHARMA Announces Quarterly Results (4QFY19); Net Profit Up 6.6% (Quarterly Result Update)

Jun 3, 2019 | Updated on Jun 3, 2019

For the quarter ended March 2019, GLENMARK PHARMA has posted a net profit of Rs 2 bn (up 6.6% YoY). Sales on the other hand came in at Rs 26 bn (up 12.4% YoY). Read on for a complete analysis of GLENMARK PHARMA's quarterly results.

GLENMARK PHARMA 2017-18 Annual Report Analysis (Annual Result Update)

Dec 19, 2018 | Updated on Dec 19, 2018

Here's an analysis of the annual report of GLENMARK PHARMA for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of GLENMARK PHARMA. Also includes updates on the valuation of GLENMARK PHARMA.

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound (Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Finally, Is the Share Price of Yes Bank Ready for a Rebound? (The 5 Minute Wrapup)

Oct 7, 2019

Here's what every individual investor must know about Yes Bank...

The One Stock I Like in this Market (The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

Rebound Riches Could be Yours With These Stocks (Profit Hunter)

Oct 4, 2019

The secret to multibagger is not big businesses, but great managements... Here's how to find them to make the most of once in a decade rebound opportunity.

5 Smart Money Stocks to Profit from the Market Rebound (The 5 Minute Wrapup)

Oct 11, 2019

Now is the time to put money in these 5 stocks to take advantage of the recovery in the economy and the markets.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

GLENMARK PHARMA SHARE PRICE


Oct 17, 2019 02:15 PM

TRACK GLENMARK PHARMA

  • Track your investment in GLENMARK PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON GLENMARK PHARMA

GLENMARK PHARMA - STERLING BIOTECH COMPARISON

COMPARE GLENMARK PHARMA WITH

MARKET STATS